THIS CAN JUMP AT ANY TIME , ONCE THEY REPORT BACK EBITDA +VE , WHICH THEY ALREADY DID 2HFY2023 , 6 MONTH ONCE THEY REPORT ON 1HFY2024 , EVERYONE WILL REGRET SELLINING AND THEY CANT EVEN BUY BACK . COMPARING THSI TO OTHER ASX ;LISTED COMPANIES WHO HAVE EVEN 3 TIMES THE MARKET CAP AND COMPANIES THAT DOESN'T EVEN HAVE ANY REVENUE , MAYNE WOULD STAND , ALL WHAT THEY NEED IS COST REDUCTION WHICH IS ACHIEVABLE , ONCE THE RESTRUCTURE IMPACT IS FELT . THIS WILL GO BACK TO WHERE IT WAS 2016 . BEST STRATEGY . REMEBER THEY NOW MAKING MONEY ON TXMD PRODUCTS WITH HALF THE OPEX AND SELLING NEXTSTELLIS WITH NO COST AMONGST THOSE PRODUCTS , 70 M SAVINGS , AND THEY WORKING ON IMPROVING THE NET SELLING PRICE THROUGH DISINTERMEDIATION .
- Forums
- ASX - By Stock
- MYX
- BOOK value $7.60 per share
MYX
mayne pharma group limited
Add to My Watchlist
2.19%
!
$4.92

BOOK value $7.60 per share, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.92 |
Change
-0.110(2.19%) |
Mkt cap ! $399.7M |
Open | High | Low | Value | Volume |
$5.03 | $5.03 | $4.86 | $1.730M | 352.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $4.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.93 | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6000 | 4.870 |
2 | 10000 | 4.860 |
3 | 51300 | 4.850 |
1 | 600 | 4.840 |
2 | 2800 | 4.800 |
Price($) | Vol. | No. |
---|---|---|
4.930 | 25000 | 1 |
4.960 | 1303 | 1 |
4.980 | 1303 | 1 |
5.000 | 1303 | 1 |
5.020 | 1303 | 1 |
Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |